Magnesium oxide nanoparticles coated with glucose can silence important genes of Leishmania major at sub-toxic concentrations
Source abstract
Abstract
The aim of this study was to investigate the effect of magnesium oxide nanoparticles (MgO NPs) and MgO NPs coated with glucose (MONPCG) on Leishmania (L) major. First, the promastigotes of L. major were separately incubated with serial concentrations of MgO NPs and MONPCG for 24, 48, and 72 h at 37 °C. Then, the cell viability of promastigotes was evaluated by MTT assay. On the other hand, the relative expression of Cpb and GP63 genes was detected by quantitative-real time PCR. Based on results, the increase of concentration, both MgO NPs and MONPCG, and incubation time led to decrease of cell viability. Moreover, the expression of Cpb and GP63 genes was decreased with increase of concentration of MgO NPs and MONPCG. Also, the increase of incubation time led to decrease of their expression in MgO NPs treated promastogotes. But, in case of MONPCG treated promastogotes, the increase of incubation time did not change the expression of Cpb and GP63. Interestingly, MONPCG could silence Cpb and GP63 genes better than MgO NPs. Note, the capability was also seen at sub-toxic concentrations of MONPCG.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Research on Leishmaniasis Studies
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (26)
Show source-provided references
1. Cutaneous leishmaniasis10.1016/S1473-3099(07)70209-8 ↗
2. Treatment of acute old World cutaneous leishmaniasis: a systematic review of the randomized controlled trials10.1016/j.jaad.2007.01.016 ↗
3. Systematic review of the adverse effects of cutaneous leishmaniasis treatment in the New World10.1016/j.actatropica.2011.02.007 ↗
4. Leishmaniasis: vaccine candidates and perspectives10.1016/j.vaccine.2012.03.068 ↗
5. Leishmania virulence factors: focus on the metalloprotease GP6310.1016/j.micinf.2012.05.014 ↗
6. Hybridization of different antisense oligonucleotides on the surface of gold nanoparticles to silence zinc metalloproteinase gene after uptake by Leishmania major10.1016/j.colsurfb.2015.03.029 ↗
7. Leishmania—macrophage interactions: insights into the redox biology10.1016/j.freeradbiomed.2011.05.011 ↗
8. A green approach for synthesis of gold and silver nanoparticles by Leishmania sp10.1007/s12010-012-9877-3 ↗
9. Silver and gold nanostructures: antifungal property of different shapes of these nanostructures on Candida species
10. Nano-based antileishmanial agents: a toxicological study on nanoparticles for future treatment of cutaneous leishmaniasis10.1016/j.tiv.2013.06.002 ↗
11. Triglyceride-coated nanoparticles: skin toxicity and effect of UV/IR irradiation on them10.1016/j.tiv.2013.05.014 ↗
12. Lectin coated MgO nanoparticle: its toxicity, antileishmanial activity, and macrophage activation
13. The cytotoxicity of silver nanoparticles coated with different free fatty acids on the Balb/c macrophages: an in vitro study10.3109/01480545.2013.878952 ↗
14. Silver nanoparticles: mechanism of antimicrobial action, synthesis, medical applications, and toxicity effects10.1186/2228-5326-2-32 ↗
15. Antimicrobial surfaces: dual‐mechanism antimicrobial polymer–ZnO nanoparticle and crystal violet‐encapsulated silicone (Adv. Funct. Mater. 9/2015)10.1002/adfm.201570063 ↗
16. Triangular gold nanoparticles conjugated with peptide ligands: a new class of inhibitor for Candida albicans secreted aspartyl proteinase10.1016/j.bcp.2014.05.020 ↗
17. Modification of nanocellulose by poly-lysine can inhibit the effect of fumonisin B1 on mouse liver cells10.1016/j.colsurfb.2014.12.047 ↗
18. Nanocellulose conjugated with retinoic acid: its capability to adsorb aflatoxin B110.1007/s10570-014-0475-0 ↗
19. Real-time PCR for detection and quantitation of Leishmania in mouse tissues10.1128/JCM.40.5.1666-1669.2002 ↗
20. Toxicity of nanomaterials10.1039/C1CS15188F ↗
21. Triclosan and antibiotic resistance in Staphylococcus aureus10.1093/jac/46.1.11 ↗
22. The effects of nano-silver on the proliferation and cytokine expression by peripheral blood mononuclear cells10.1016/j.intimp.2007.08.025 ↗
23. Cellular responses induced by silver nanoparticles: in vitro studies10.1016/j.toxlet.2008.04.009 ↗
24. Silver nanoparticle applications and human health10.1016/j.cca.2010.08.016 ↗
25. Cytotoxicity and genotoxicity of silver nanoparticles in human cells10.1021/nn800596w ↗
26. In vitro toxicity of silver nanoparticles at noncytotoxic doses to HepG2 human hepatoma cells10.1021/es900754q ↗